Can You Exercise a Stock Option With a Nonrecourse Note and Start Your QSBS Holding Period?

Published on Nov 20, 2025 — 7 min read

Stock Options

Photo by Marcus Reubenstein / Unsplash

Summary

Can You Exercise a Stock Option With a Nonrecourse Note and Start Your QSBS Holding Period?

If you're a founder or early employee with stock options, you've probably heard about Qualified Small Business Stock (QSBS) — the IRS provision that lets you exclude up to $10 million in gains when you sell qualifying stock. The holy grail is to exclude all your gains from tax, and that only works if you hold the stock long enough.

One of the most common questions I get is whether you can exercise options using a nonrecourse promissory note — basically, borrowing the exercise price from a lender without any personal liability — and still start the QSBS holding period. The appeal is obvious: exercise early, start the clock, and wait for the company to succeed.

The short answer is: generally no. But the analysis is nuanced, and there are strategies to achieve your goals legally.

What a Nonrecourse Note Is (And Why Founders Love Them)

A nonrecourse note is a promissory note that makes the borrower not personally liable for repayment. If you borrow using a nonrecourse note, the lender's only remedy if you don't repay is to take the collateral — in this case, your stock. The lender cannot come after your house, your car, or your other assets.

This is hugely attractive to founders exercising options because it lets you exercise without cash outlay. You get the shares, the lender gets a lien on those same shares, and if the company tanks, the lender's claim is worthless. You walk away with nothing, but you don't owe the lender anything either.

From a founder's perspective, this solves the cash problem. Exercise a million options at $1 per share? That's $1 million you might not have. A nonrecourse note lets you buy today and pay later (or never) from exit proceeds.

The QSBS Problem: "Acquired by the Taxpayer in Exchange for Money or Other Property"

QSBS gets its tax-free treatment from Section 1202 of the Internal Revenue Code. To qualify, stock must be "acquired by the taxpayer at its original issue in exchange for money or other property." This language is critical.

The IRS and tax counsel have generally interpreted this to mean that the taxpayer must have given something of value — actual money, property, or services (if you're doing early exercise with an 83(b) election). The question with a nonrecourse note is whether signing a note counts as "payment" for Section 1202 purposes.

The consensus view among tax practitioners is that a nonrecourse note does not constitute adequate payment because the borrower has not truly "parted with" anything of value. You haven't paid cash, you haven't transferred property, and if the loan goes bad, you have no obligation to repay. The IRS has never issued formal guidance saying nonrecourse notes are acceptable for QSBS, and several tax authorities have cautioned against relying on them.

The key case here is Reg. Section 1.1202-1(e), which states that stock is acquired "in exchange for money or other property" only when there is a genuine economic exchange. A nonrecourse note where the borrower has no recourse arguably falls short of that standard because the borrower retains the ability to walk away without real economic consequence.

The IRS Position and Relevant Guidance

The IRS has been cautious about nonrecourse notes in the equity compensation context. In the 409A space (valuations for option pricing), the IRS has expressed concern about nonrecourse notes because they can enable below-fair-market-value exercise prices without economic reality.

While there's no formal QSBS ruling on nonrecourse notes, the principle underlying Section 1202 — that stock must be genuinely acquired through real payment — suggests the IRS would challenge a nonrecourse note exercise in audit. The burden would be on you to prove the note represented real payment.

More troubling: if the IRS disallows QSBS treatment on the grounds that the acquisition didn't qualify, it will likely also question whether the holding period even starts. You could find yourself in a position where you thought you exercised in 2020, started the five-year clock, and in 2025 are told the holding period never started because the original acquisition wasn't valid.

Recourse vs. Nonrecourse: Why the Distinction Matters

A recourse note is the opposite. If you borrow using a recourse note, the lender can come after you personally if you don't repay. You have real skin in the game — if the company fails and the stock is worthless, you still owe the lender the full amount (unless discharged in bankruptcy).

From a tax perspective, a recourse note is much more defensible under Section 1202. You've genuinely obligated yourself to pay real money. The fact that you're betting the company will succeed and you'll be able to repay from proceeds is normal borrowing. Many founders do this successfully — they exercise with a recourse note (often from the company or from a third-party lender), and they pay it back at exit.

The economic reality test cuts in your favor with a recourse note. You could lose your house if the company fails. That's real payment in the tax world.

The Section 83 Angle: When Stock Acquisition Is About More Than Just QSBS

There's another layer to this analysis involving Section 83, the provision that deals with restricted stock and options.

When you exercise an option, you acquire shares. If those shares are subject to vesting or a forfeiture condition, Section 83 says you don't have a completed acquisition for tax purposes until those conditions lapse. If you file an 83(b) election, you accelerate the taxation and the acquisition date.

A nonrecourse note can create ambiguity about whether you've actually received stock "in the taxpayer's hands" for Section 83 purposes. If the lender retains control or a deep security interest, it's arguable that the stock hasn't really been transferred to you — it's being held as collateral. This muddies the acquisition date, which affects both your basis calculation and the start of the QSBS holding period.

This is why many tax advisors recommend that if you use a promissory note (recourse or nonrecourse) to exercise, you also file an 83(b) election to establish a clear acquisition and taxation date. But even an 83(b) election may not save you with a nonrecourse note if the fundamental problem is that you haven't made real payment.

Alternative Approaches to Start the QSBS Clock Without Cash

If a nonrecourse note is risky, what are your options?

Recourse Note: This is the most straightforward. Borrow the exercise price under a recourse promissory note (from the company, a bank, or a private lender), file an 83(b) if the stock is restricted, and start the clock. The IRS is comfortable with this because you have genuine economic risk. The downside is you're personally liable if the company fails.

Early Exercise with 83(b): Some companies allow employees to exercise options before they vest, with an 83(b) election. You pay cash now, the shares are restricted but you've filed 83(b), and the holding period starts. If you vest, great. If you don't, you forfeit the shares but keep any gains. This is economically honest and less risky than borrowing, but it requires cash outlay upfront.

Cashless Exercise at Exit: The most common approach. Exercise and sell in a single transaction at exit or IPO, when you have liquidity. You realize gains, pay tax, and QSBS doesn't help (because you've held the stock for only moments). But this is the safest path from a tax-audit perspective.

Company Loan Program: Some well-capitalized companies loan money to employees to exercise options. If the company loans you cash at a fair interest rate, it's a legitimate recourse loan, and you start the clock. The company has a note receivable, you have stock and a debt obligation, and the IRS is fine with it.

Practical Guidance: What Should a Founder Do?

If you're an early-stage founder with options and you're thinking about exercising to start the QSBS clock, here's my advice:

Don't rely on a nonrecourse note. The risk that it won't qualify for QSBS is real, the IRS hasn't blessed them, and the cost of being wrong is steep. You might spend cash on the option exercise only to learn years later that the holding period doesn't count.

If you have cash, do an early exercise with 83(b) election. It's the cleanest path. You own the stock from day one, the holding period is clear, and there's no note hanging over your head. Yes, you pay tax on the spread between strike price and FMV, but you've locked in a holding period that can't be challenged.

If you don't have cash, consider a recourse note. Work with your company to see if they'll loan you the exercise price (with a note). Or find a private lender (sometimes equity compensation platforms facilitate this). You'll have personal liability if the company fails, but that's honest borrowing, and the IRS won't question your QSBS eligibility.

If neither option works, wait. There's no rule that says you must exercise your options early. You can exercise later when you have liquidity, or do a cashless exercise at exit. It's not as tax-efficient from a QSBS standpoint, but it beats relying on a nonrecourse note and being wrong.

Risk-Reward Analysis: When Is Early Exercise Worth It?

Ultimately, this is a calculation. Early exercise costs money (either cash or a recourse loan obligation). The benefit is starting the QSBS clock earlier, which gives the company more time to succeed and compounds the tax savings if it does.

If you think there's a strong chance the company will exit profitably and generate QSBS gains above $10 million, early exercise is worth the cost. If you're less confident, or if the company is less mature, the benefit may not justify the risk and expense of exercising early.

A nonrecourse note is tempting because it purports to let you have it both ways: early exercise without economic commitment. But tax law doesn't work that way. The IRS wants to see genuine payment, genuine economic risk, or clear and unambiguous language establishing the acquisition date. A nonrecourse note provides none of these convincingly.

Do the exercise properly — with cash, with 83(b), or with a recourse note. Your future self will thank you when you're not scrambling to defend the QSBS basis of a multimillion-dollar gain.

Can You Exercise a Stock Option With a Nonrecourse Note and Start Your QSBS Holding Period?

Summary